_MACHINE TRANSLATION_
The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer”, the “Company”) hereby publishes, as an attachment to this current report, the resolutions adopted by the Ordinary General Meeting of Shareholders (the “OGM”), which was resumed on 7 July 2026 following the adjournment announced on 23 June 2026, together with the voting results.
A shareholder present at the OGM proposed the adoption of Resolution No. 20/06/2026 regarding an adjournment of the OGM proceedings until 16 July 2026 at 10:30 a.m. The aforementioned resolution was adopted in accordance with the draft submitted by the shareholder.
Consequently, the Management Board of the Issuer hereby informs that the OGM proceedings have been adjourned until 16 July 2026 at 10:30 a.m. The resumed session of the OGM will be held at the Company’s registered office in Wrocław, at 57-59 Bierutowska Street, Building III.
Detailed legal basis: § 20(1)(3)-(9) of the Regulation of the Minister of Finance of 6 June 2025 on current and periodic information to be disclosed by issuers of securities and on conditions for recognizing as equivalent information required under the laws of a non-member state.
Attachment:
– Draft resolution submitted by a shareholder.
BCX RB ESPI 23.2026 Treść projektów uchwał ZWZ – załącznik 1
– Text of the adopted resolution.
BCX RB ESPI 23.2026 Uchwały podjęte ZWZ – załącznik 2
Signatures of persons representing the Company:
Łukasz Bzdzion – President of the Management Board
Paweł Wielgus – Member of the Management Board